|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q86823457
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235936.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q86823457
|
|
024
|
|
|
‡a
0000-0002-7580-0913
‡2
orcid
|
|
024
|
|
|
‡a
57202387849
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q86823457
|
|
100
|
0 |
|
‡a
Thomas Robert
‡c
researcher (ORCID 0000-0002-7580-0913)
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Thomas Robert
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A simple and novel technique for regional citrate anticoagulation during intermittent hemodialysis may obviate the need for calcium monitoring
|
|
670
|
|
|
‡a
Author's Advocacy for a European network of renal intensive care units
|
|
670
|
|
|
‡a
Author's Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)
|
|
670
|
|
|
‡a
Author's Calcium salt during hyperkalemia
|
|
670
|
|
|
‡a
Author's [Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients]
|
|
670
|
|
|
‡a
Author's Comparison of Scheduled vs Emergency-Only Dialysis in Undocumented Immigrants With End-stage Renal Disease
|
|
670
|
|
|
‡a
Author's Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.
|
|
670
|
|
|
‡a
Author's LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II trial
|
|
670
|
|
|
‡a
Author's Molecular Insights into the Pathogenesis of IgA Nephropathy.
|
|
670
|
|
|
‡a
Author's Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
|
|
670
|
|
|
‡a
Author's Red urine, updated for the nephrologist: a case report.
|
|
670
|
|
|
‡a
Author's Rheopheresis: A new therapeutic approach in severe calciphylaxis
|
|
670
|
|
|
‡a
Author's Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
|
|
670
|
|
|
‡a
Author's Sodium is the secret re-agent of bicarbonate therapy during hyperkalemia
|
|
670
|
|
|
‡a
Author's Steroid therapy in children with IgA nephropathy
|
|
670
|
|
|
‡a
Author's The Potential Clinical Significance of the Biomarker IgA1
|
|
670
|
|
|
‡a
Author's Triage of Patients Suspected of COVID-19 in Chronic Hemodialysis: Eosinophil Count Differentiates Low and High Suspicion of COVID-19
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/311496199
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|180917056
|
|
909
|
|
|
‡a
(orcid) 0000000275800913
‡9
1
|
|
909
|
|
|
‡a
(scopus) 57202387849
‡9
1
|
|
919
|
|
|
‡a
signalingofserumamyloidathroughreceptorforadvancedglycationendproductsasapossiblemechanismforuremiarelatedatherosclerosis
‡A
Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
‡9
1
|
|
919
|
|
|
‡a
simpleandnoveltechniqueforregionalcitrateanticoagulationduringintermittenthemodialysismayobviatetheneedforcalciummonitoring
‡A
A simple and novel technique for regional citrate anticoagulation during intermittent hemodialysis may obviate the need for calcium monitoring
‡9
1
|
|
919
|
|
|
‡a
advocacyforaeuropeannetworkofrenalintensivecareunits
‡A
Advocacy for a European network of renal intensive care units
‡9
1
|
|
919
|
|
|
‡a
belataceptinrenaltransplantrecipientwithmildimmunologicriskfactorapilotprospectivestudybelacor
‡A
Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)
‡9
1
|
|
919
|
|
|
‡a
calciumsaltduringhyperkalemia
‡A
Calcium salt during hyperkalemia
‡9
1
|
|
919
|
|
|
‡a
clinicalmanagementofpatientswithhemophiliaainnephrologydiagnosticandtherapeuticchallengesillustratedbythecasesof2patients
‡A
[Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients]
‡9
1
|
|
919
|
|
|
‡a
comparisonofscheduledvsemergencyonlydialysisinundocumentedimmigrantswithendstagerenaldisease
‡A
Comparison of Scheduled vs Emergency-Only Dialysis in Undocumented Immigrants With End-stage Renal Disease
‡9
1
|
|
919
|
|
|
‡a
immunosuppressivetreatmentinchildrenwithiganephropathyandtheclinicalvalueofpodocytopathicfeatures
‡A
Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.
‡9
1
|
|
919
|
|
|
‡a
ldlapheresistodecreasesflt1duringearlyseverepreeclampsiareportof2casesfromadiscontinuedphase2trial
‡A
LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II trial
‡9
1
|
|
919
|
|
|
‡a
molecularinsightsintothepathogenesisofiganephropathy
‡A
Molecular Insights into the Pathogenesis of IgA Nephropathy.
‡9
1
|
|
919
|
|
|
‡a
recurrentiganephropathyispredictedbyalteredglycosylatedigaautoantibodiesandsolublecd89complexes
‡A
Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
‡9
1
|
|
919
|
|
|
‡a
redurineupdatedforthenephrologistacasereport
‡A
Red urine, updated for the nephrologist: a case report.
‡9
1
|
|
919
|
|
|
‡a
rheopheresisanewtherapeuticapproachinseverecalciphylaxis
‡A
Rheopheresis: A new therapeutic approach in severe calciphylaxis
‡9
1
|
|
919
|
|
|
‡a
sodiumisthesecretreagentofbicarbonatetherapyduringhyperkalemia
‡A
Sodium is the secret re-agent of bicarbonate therapy during hyperkalemia
‡9
1
|
|
919
|
|
|
‡a
steroidtherapyinchildrenwithiganephropathy
‡A
Steroid therapy in children with IgA nephropathy
‡9
1
|
|
919
|
|
|
‡a
potentialclinicalsignificanceofthebiomarkeriga1
‡A
The Potential Clinical Significance of the Biomarker IgA1
‡9
1
|
|
919
|
|
|
‡a
triageofpatientssuspectedofcovid19inchronichemodialysiseosinophilcountdifferentiateslowandhighsuspicionofcovid19
‡A
Triage of Patients Suspected of COVID-19 in Chronic Hemodialysis: Eosinophil Count Differentiates Low and High Suspicion of COVID-19
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
SUDOC|199568146
|
|
996
|
|
|
‡2
NTA|079895638
|
|
996
|
|
|
‡2
BNF|14967386
|
|
996
|
|
|
‡2
SUDOC|271584238
|
|
996
|
|
|
‡2
NUKAT|n 94315111
|
|
996
|
|
|
‡2
LC|no2017036782
|
|
996
|
|
|
‡2
ISNI|0000000403355042
|
|
996
|
|
|
‡2
SUDOC|200217666
|
|
996
|
|
|
‡2
SUDOC|121657663
|
|
996
|
|
|
‡2
RERO|A024592902
|
|
996
|
|
|
‡2
DNB|135928370
|
|
996
|
|
|
‡2
DNB|117343110
|
|
996
|
|
|
‡2
ISNI|0000000409132392
|
|
996
|
|
|
‡2
SUDOC|281074127
|
|
996
|
|
|
‡2
SUDOC|261577816
|
|
996
|
|
|
‡2
SUDOC|272853801
|
|
996
|
|
|
‡2
LC|n 2021014168
|
|
996
|
|
|
‡2
ISNI|0000000068685019
|
|
996
|
|
|
‡2
BNF|18142730
|
|
996
|
|
|
‡2
SUDOC|185629105
|
|
996
|
|
|
‡2
ISNI|0000000068680285
|
|
996
|
|
|
‡2
PLWABN|9810541427805606
|
|
996
|
|
|
‡2
SUDOC|223558192
|
|
996
|
|
|
‡2
ISNI|0000000431597196
|
|
996
|
|
|
‡2
SUDOC|270425179
|
|
996
|
|
|
‡2
ISNI|0000000110659456
|
|
996
|
|
|
‡2
PTBNP|1198101
|
|
996
|
|
|
‡2
RERO|A003487480
|
|
996
|
|
|
‡2
SUDOC|132636093
|
|
996
|
|
|
‡2
SUDOC|113113552
|
|
996
|
|
|
‡2
RERO|A011873046
|
|
996
|
|
|
‡2
ISNI|0000000359286632
|
|
996
|
|
|
‡2
PLWABN|9810595539905606
|
|
996
|
|
|
‡2
SUDOC|260094579
|
|
996
|
|
|
‡2
BNF|14028406
|
|
996
|
|
|
‡2
SUDOC|147581117
|
|
996
|
|
|
‡2
SUDOC|02906855X
|
|
996
|
|
|
‡2
SUDOC|234613955
|
|
996
|
|
|
‡2
DNB|126421595
|
|
996
|
|
|
‡2
ISNI|0000000080452760
|
|
996
|
|
|
‡2
SUDOC|155763806
|
|
996
|
|
|
‡2
SUDOC|280434944
|
|
996
|
|
|
‡2
SUDOC|250576694
|
|
996
|
|
|
‡2
SUDOC|140332987
|
|
996
|
|
|
‡2
PTBNP|112184
|
|
996
|
|
|
‡2
DNB|1055116354
|
|
996
|
|
|
‡2
SUDOC|147460662
|
|
996
|
|
|
‡2
BNF|17167378
|
|
996
|
|
|
‡2
ISNI|0000000431979418
|
|
996
|
|
|
‡2
RERO|A003750969
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Robert, Thomas,
‡2
SUDOC|180917056
‡3
title: (0.67, 'recurrentiganephropathyispredictedbyalteredglyclosylatedigacomplexesandiscontrolledbypulsesteroidtherapy', 'recurrentiganephropathyispredictedbyalteredglycosylatedigaautoantibodiesandsolublecd89complexes')
‡3
suggested
|
